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(BP) test with methacholine, A 10% daily variability of PEFR for at least half 
of the monitoring days was considered an index of bronchial hyperresponsiveness 
(BHR). BP results were scored as; moderate-severe BHR (PC20FEV1 <  4 mg/ml), 
mild or border-line BHR (PC00FEV1 4-64 mg/ml). Thirty-one subjects showed a 
bronchial obstruction, reversible in 27 of them; the remaining 4 subjects showed a 
reversible airway obstruction after 2-week treatment with inhaled steroids. Twenty 
subjects performed PEFR monitoring and BP; 5 were identified to have BHR 
by the analysis of PEFR and 3 of these had a severe-moderate BHR at the BP 
test. BP test revealed 12 patients with severe-moderate BHR and 8 with mild 
BHR. We conclude that asthma diagnosis can be done, in a majority of patients, 
by detecting a reversible bronchial obstruction and that PEFR monitoring should 
not be considered a necessary step in the algorithm suggested for the diagnosis 
of asthma. However, PEFR monitoring could be delayed to further confirm the 
diagnosis of asthma in those patients with mild or border-line BHR.
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Determinants of Willingness to Participate in Self Management Asthma 
Programs
Joost J. den Otter, Henric ter Horst, Annelies Jacobs, Constant P. van Schayck, 
Chris van Weel. Nijmegen University, Dept o f General Practice & Social 
Medicine, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands
Introduction: A lot of studies have been performed on self management of asthma 
programs (SMAP), Controlled studies did not detect a significant improvement of 
clinical outcome. A possible explanation is that SMAP were also given to patients 
not interested (and thus not compliant) in such programs. In this pilo ts tudy we 
describe the willingness of asthma patients from one general practice to partici­
pate in a SMAP. Potential determinants studied included age, education, gender, 
severeness and/or duration of disease and smoking habits.
Methods: All asthma patients known to the general practitioner between 18-50 
years were invited. All patients had a spirometry assessment, made an assessment 
of disease severity on a VAS-scale, control of inhaler technique, an interview using 
Wilsons criteria (Am J Med 1993; 94:564-75) and finally their willingness to 
participate in a SMAP was assessed.
Results: 23 patients (8 male) out of 31 participated. Mean age ±  SD was 41 ±  
9 years, mean duration of asthma 18 ±  15 years. Overall inhaler technique was 
insufficient in 5 patients. Objective and subjective severeness had 9 disconcordant 
pairs. 14 Participants were willingly to participate in a SMAP. This study could 
not detected a relation between education and willingness.
Conclusion: Not all patients want to participate in a SMAP. Determinants of 
willingness are: age, sex, objective and subjective severeness of asthma,
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Initial PEF as Predictor of Respiratory Failure in Asthmatic Patients
B. Milenkovic, V. Petrovic, S. Radovanovic, A. Ilic, Institute fo r  Pulmonary 
Diseases and TB, University Clinical Centre, Belgrade, Yugoslavia
The respiratory failure (RF) is one of the possible consequences of bronchia] 
asthma (BA) exacerbations. The aim of this study was to determine the validity of 
PEF as predictor of RF.
Ninety five patients (70 females, mean age 37.8 ±  14.2 yrs) presenting to a hospital 
with asthma exacerbations were studied. The severity of BA was assessed accord­
ing to the symptoms, observation and lung function proposed by the International 
consensus report from 1992. These patients had initial PEF and arterial blood 
gases measured whilst breathing air. The initial PEF as a percentage of predicted 
was estimated by reference to a standard nomogram.
There was no correlation between initial PEF and Pa02 (r »  0.27, p >  0.05). On 
admission, there were 65 patients (68%) with RF. Forty one patients had a Pa02 
<  8kPa, five had PaC02 > 6kPa and 19 had both. All patients with RF had initial 
PEF less than 2 6 0 1/min or 52% o f predicted.
We conclude there is high incidence of RF in BA exacerbations (68%) and no cor­
relation between initial PEF and Pa02, These results support the recommendation 
that asthmatics presenting to a hospital with a PEF less than 50% of predicted 
value should have arterial blood gases estimated,
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An Analysis and Comparison of Asthma Chronic Disease Management 
Programme (CDMP) Data, and Prescribing Analysis and Cost (PACT) D ata 
in Suffolk
L. Pearce. Suffolk Health, Ipswicht Suffolk, England
Introduction: The asthma CDMP is an organized programme for management of 
patients with asthma in primary care. Data is collected on patient numbers, age 
and sex, numbers on prophylactic medication, and hospital admissions. PACT data 
is an analysis of all prescriptions dispensed.
Method: 1994-5 CDMP data reported to Suffolk Health was analysed and where 
appropriate compared with PACT data (three month period in 1995).
Results: 1. CDMP asthma incidence
Ages 0 - 1 4 Ail age groups
Mcun reported incidence 10,3% 6.7%
Runge 2.2K-3 0.1 %
2. PACT Mean Bronchodilator prescribíng/CDMP reported asthmatic = 1,7 items/3 
months (range 0-6.87)
3. CDMP Mean % o f asthmatics on prophylactic therapy = 60.25% (5.2%-120.7%)
4. PACT Mean prophylactic/Bronchodilator prescribing rate -  1.64 (range 1.37- 
2.66)
5. Mean Variation between CDMP % of asthmatics on prophylactic therapy and 
PACT prophylactic/Bronchodilator prescribing rate =1.17 (range 0.06-2.91)
6. Mean hospital admissions = 6,9 (range 0-44). No relationship was found 
between prophylactic prescribing and admissions
Discussion -  In Suffolk general practices (1994-5):
Reported adult (1.6.9M4.7%) and paediatric (2.2%-30,I%) asthma diagnosis 
appears to show considerable variance.
Reported and recorded prescribing data appears to show considerable variance. 
Reported prescribing practice does not appear, in general, to relate to recorded 
prescribing data.
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Evaluation of an Education Program in the Follow Up of Asthma Patients
R. Gene, G. Apelbaum, Div. Neumonologia, Hospital de Clínicas J. de San 
Martin, Universidad de Buenos Aires, Argentina
Wb had developed an education program (EDUCASMA) based on International 
Guidelines (NIH-USA-1992). We applied them on 300 patients which results were 
presented in ERS Annual Congress, Barcelona 1995 (Abst: 2576-; Europ, Resp, 
J). After a follow up period of 14 +/— 4 months we were able to obtain results of 
clinical, functional, quality of life scores and treatment compliance.
Patients’ Treatments were conducted by: pneumonologist on a regular monthly 
schedule (group A n = 29); pneumonologist on a monthly schedule partially 
fulfilled (group B n = 13 ptes); generalist (group C n = 8 ptes).
Results: After the follow up period FEV1 and PEFR were not significant different 
as a whole or in each individual group. (FEVI = 76.3 +/— 24.7; «evaluation FEVl 
=s 77,64 +/— 23, p = 0.55 t Test n = 50), One subgroup of ptes who had initially 
FEV1 below 60% of predicted values show an significant improvement (n = 12; 
44.3 + / -  9.6% to 58,3 + /-  13.3; p = 0.007 t Test).
Seven possibles limitations in the daily activities (Quality of life) improved signif­
icantly after education (n « 50; p -  0.0001). These changes were not recorded in 
group C (n = 8, Wilcoxon Rank Test p > 0,05),
Asthma Severity (AS) was evaluated by an score using emergency visits number 
and nocturnal asthma degrees before and after education program.
We detected improvement in A and B groups (p < 0,02) but not in C group (p > 
0.6).
Compliance of treatment improved in group A (p = 0.01 t Test). Improvements 
significant were not found in B and C.
Conclusions: Education was in this experience an useful tool in asthma treatment 
improving quality of life, compliance of treatment and severity of asthma. It was 
more effective in ptes who were seen by pneumonologist using actual guidelines 
management including habitual programmed visits.
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Discriminative and Evaluative Properties of a New Simple Measure o f 
Quality of Life in Asthma
E.A. White, P,W Jones. Division o f Physiological Medicine, St. George's 
Hospital Medical School, London, SW17 ORE, UK
The AQ20 is a new short and simple, 20 item asthma specific quality of life 
(QoL) questionnaire designed for routine clinical use which takes 2.5 minutes 
to complete and score. Its discriminative and evaluative properties have been 
examined by comparing its performance with that of 2 more complex measures 
- the St. George’s Respiratory Questionnaire (SGRQ) and the Asthma Quality 
of Life Questionnaire (AQLQ), 90 asthmatic patients (59 = female) completed 
the 3 questionnaires at baseline and again 12 weeks later (n = 75). Mean age 
was 46 years (range 17—79), mean FEVj was 72.5 ±  24.8 (sd) % predicted. At 
baseline, the correlation between the AQ20 and the SGRQ Total score was 0,86 and 
between the AQ20 and the AQLQ Total score it was —0.80 (both p < 0.0001). The 
correlation between change (A) in AQ20 and ASGRQ Total score was 0,45 (p < 
0 .0001) and between AAQ20 and A AQLQ Total score it was -0 .42 (p =  0.0002), 
To estimate the degree of change between assessments, the coefficient o f  variation 
for the change in scores was calculated as the standard deviation of the difference 
between the two measurements divided by the mean, expressed as a percentage. 
The AQ20 and the SGRQ showed the greatest change between assessments (cv = 
28% for both). The cv for the AQLQ was 17%, This suggests that the AQ20 may 
be at least as responsive as the AQLQ. However, responsiveness to change can 
only be tested fully in an intervention study. We conclude that the AQ20 m ay have 
similar properties to more complex measures.
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Changes in Clinic Practice and Control of Asthma, as Assessed by 
Actual/Best Pef O ver 14 Years, 1980-1993/4
C.K. Connolly 1, S.M. Alcock, R.J. Prescott2. Darlington Memorial Hospital, 
United Kingdom; 1 University o f Newcastle upon Tyne, United Kingdom;
2 University o f Edinburgh, United Kingdom
Major efforts have been made to improve asthma management in the last 20 
years, particularly with appropriate prophylactic inhaled corticosteroids (INH.ST).
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